Table 7.
n | Health Status | Dosage (mg) | Duration (weeks) | Adverse Event | Ref. |
---|---|---|---|---|---|
93 | Normotensive and Stage I hypertension | 150 | 6 | No effects on liver, kidneys, electrolytes, and hematology biomarkers | [73] |
49 | Healthy | 150 | 8 | Increased TNF-α by 0.11 pg/mL, p < 0.05 | [89] |
40 | Athletes | 1000 | 6 | No adverse events reported | [90] |
30 | Chronic Hepatitis C | 250–5000 | 4 | No adverse effects on liver function but mild gastrointestinal discomfort | [91] |
Abbreviations: HTN, hypertension; TNF-α, tumor necrosis factor.